article · Health Science Reports
The abstract on record is too brief for a reliable plain-language summary, so none has been generated.
The MDA and LDH levels were not reliable for distinguishing BM status in this study population; rather, CRP was a stronger biomarker for differentiating BM from AM. Larger prospective studies are required to investigate the role of these biomarkers in BM cases.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1002/hsr2.72376
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.